ロード中...
Improved Risk-Adjusted Survival for Melanoma Brain Metastases in the Era of Checkpoint Blockade Immunotherapies: Results from a National Cohort
The successes of checkpoint blockade immunotherapy (CBI) and BRAF(V600)-targeted therapy trials have generated substantial promise for revolutionizing the management of patients with advanced melanoma. However, because early clinical trials of CBIs and BRAF(V600)-targeted therapy either excluded or...
保存先:
| 出版年: | Cancer Immunol Res |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6230261/ https://ncbi.nlm.nih.gov/pubmed/30002157 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2326-6066.CIR-18-0067 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|